Orylmyte (Dermatophagoides Pteronyssinus, Dermatophagoides Farinae)

Dermatophagoides pteronyssinus, the active ingredient in Orylmyte, is a biologic allergen extract presented as a standardized extract for subcutaneous use. It is employed in allergen immunotherapy to modify immune response in individuals with dust‑mite allergy. GNH USA supplies Orylmyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Orylmyte is used in allergen immunotherapy targeting the dust‑mite sensitisation pathway. - Allergic rhinitis: reduces nasal congestion, sneezing and itching associated with dust‑mite exposure. - Allergic asthma: helps lower bronchial hyper‑responsiveness and frequency of asthma attacks. - Atopic dermatitis: may improve skin inflammation linked to dust‑mite allergens.

Orylmyte may exhibit several adverse reactions following subcutaneous administration.

Common Side Effects: - Local redness:   -    -  ... ... ...